Teladoc Health (NYSE:TDOC – Get Free Report) issued an update on its third quarter 2023 earnings guidance on Tuesday morning. The company provided EPS guidance of -$0.50–$0.40 for the period, compared to the consensus EPS estimate of -$0.33. The company issued revenue guidance of $650.00 million-$675.00 million, compared to the consensus revenue estimate of $663.11 […]